We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Tubulin beta-III antibody (Tuj -1)
Tubulin beta-3 chain
Tubulin beta-4 chain
Tubulin beta-III
Gene name : TUBB3
Tubulin beta-4 chain
Tubulin beta-III
Gene name : TUBB3
As low as
$306.10
In stock
Ref
00106716
This component of microtubules has a role in axon guidance and maintenance.
| ID Covalab | mab0054-P |
|---|---|
| Product type | Loading controls, Primary antibodies |
| Clonality | Monoclonal antibody |
| Clone | Tuj-1/TubIII/4G3 |
| Isotype | IgG1 / Kappa |
| Raised in | Mouse |
| Immunogen | CIII beta-Tubulin protein (Cter domain) |
| Activity cross reaction | Reacts with human 55 kDa TUBB3 protein. |
| Species | Hu |
| Labelling | None |
| Form | Purified (protein A) |
| Preservative | None |
| Storage instructions | Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt. |
| Target | Tubulin beta-3 chain |
| Uniprot ID | Q13509 |
| Gene ID | 10381 |
| Applications | ELISA, ICC, IF, IHC, IP, WB |
| Working dilutions | Optimal dilution should be determined by the end user. The following are guidelines only : IHC (1:100 - 1:500) IP (1:50 - 1:200) WB (1:200 - 1:1000) |
| Publication | * Tóth C et al. Int J Mol Med. 2017. * Vilmar A et al. Lung Cancer. 2012 Mar,75(3):306-12. * Zimling ZG, et al. Cancer Chemother Pharmacol. 2012 Nov,70(5):743-54. * Vilmar AC et al. Clin Cancer Res. 2011 Aug 1,17(15):5205-14. *Charles Dumontet et al., BCIRG 001 Molecular Analysis: Prognostic Factors in Node-Positive Breast Cancer Patients Receiving Adjuvant Chemotherapy. August 2010 * Sève P et al. Clin Cancer Res. 2007 Feb 1,13(3):994-9. * Sève P et al. Cancer Chemother Pharmacol. 2007 Jun,60(1):27-34. |
Write Your Own Review